The Prognostic Value of microRNA-126 and Microvessel Density in Patients With Stage II Colon Cancer: Results From a Population Cohort

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-014-0254-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Value of microRNA-126 and CRK Expression in Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Prognostic Impact of CDX2 in Stage II Colon Cancer: Results From Two Nationwide Cohorts

British Journal of Cancer
Cancer ResearchOncology
2018English

Prognostic Impact of Mutation Profiling in Patients With Stage II and III Colon Cancer

Scientific Reports
Multidisciplinary
2016English

Identification of a Sixteen-microRNA Signature as Prognostic Biomarker for Stage II and III Colon Cancer

Oncotarget
Oncology
2017English

Effect of Oncotype DX Colon Cancer Test Results on Treatment Recommendations in Patients With Stage II Colon Cancer: Preliminary Results.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

MicroRNA-9-5p-CDX2 Axis: A Useful Prognostic Biomarker for Patients With Stage II/III Colorectal Cancer

Cancers
Cancer ResearchOncology
2019English

Screening Mammography Use and Chemotherapy Among Female Stage II Colon Cancer Patients: A Retrospective Cohort Study

BMC Health Services Research
Health Policy
2010English

Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study

Journal of Surgical Research
Surgery
2020English

Oncogenic Role and Prognostic Value of MicroRNA-937-3p in Patients With Breast Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy